195 related articles for article (PubMed ID: 31177184)
21. Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.
Rautio N; Jokelainen J; Saaristo T; Oksa H; Keinänen-Kiukaanniemi S; ; Peltonen M; Vanhala M; Korpi-Hyövälti E; Moilanen L; Saltevo J; Niskanen L; Tuomilehto J; Uusitupa M
J Prim Care Community Health; 2013 Jan; 4(1):59-66. PubMed ID: 23799691
[TBL] [Abstract][Full Text] [Related]
22. Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation.
Bodicoat DH; Khunti K; Srinivasan BT; Mostafa S; Gray LJ; Davies MJ; Webb DR
Diabet Med; 2017 Mar; 34(3):396-404. PubMed ID: 26871995
[TBL] [Abstract][Full Text] [Related]
23. Baseline characteristics of participants in the Kerala Diabetes Prevention Program: a cluster randomized controlled trial of lifestyle intervention in Asian Indians.
Sathish T; Oldenburg B; Tapp RJ; Shaw JE; Wolfe R; Sajitha B; D'Esposito F; Absetz P; Mathews E; Zimmet PZ; Thankappan KR
Diabet Med; 2017 May; 34(5):647-653. PubMed ID: 27279083
[TBL] [Abstract][Full Text] [Related]
24. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study.
de Mello VD; Lindström J; Eriksson J; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Sundvall J; Laakso M; Tuomilehto J; Uusitupa M
Diabetes Care; 2012 Feb; 35(2):211-7. PubMed ID: 22210578
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
Armato JP; DeFronzo RA; Abdul-Ghani M; Ruby RJ
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):781-789. PubMed ID: 30224284
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms underlying the relationship between health literacy and glycemic control in American Indians and Alaska Natives.
Brega AG; Ang A; Vega W; Jiang L; Beals J; Mitchell CM; Moore K; Manson SM; Acton KJ; Roubideaux Y;
Patient Educ Couns; 2012 Jul; 88(1):61-8. PubMed ID: 22497973
[TBL] [Abstract][Full Text] [Related]
28. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
[TBL] [Abstract][Full Text] [Related]
29. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.
Campbell MD; Sathish T; Zimmet PZ; Thankappan KR; Oldenburg B; Owens DR; Shaw JE; Tapp RJ
Nat Rev Endocrinol; 2020 Jul; 16(7):395-400. PubMed ID: 32060416
[TBL] [Abstract][Full Text] [Related]
30. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
31. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
32. [Two-year follow-up for patients with pre-diabetes that reverted to normal glucose in the first year].
Lu YH; Lu JM; Wang SY; Li CL; Liu LS; Zheng RP; Tian H; Wang XL; Yang LJ; Zhang YQ; Pan CY
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1394-7. PubMed ID: 18953877
[TBL] [Abstract][Full Text] [Related]
33. Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).
Fritsche A; Wagner R; Heni M; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Dannecker C; Fritsche L; Valenta V; Schick R; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Dambeck U; Stumvoll M; Blüher M; Birkenfeld AL; Schwarz P; Hauner H; Clavel J; Seißler J; Lechner A; Müssig K; Weber K; Laxy M; Bornstein S; Schürmann A; Roden M; de Angelis MH; Stefan N; Häring HU
Diabetes; 2021 Dec; 70(12):2785-2795. PubMed ID: 34531293
[TBL] [Abstract][Full Text] [Related]
34. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
Pilmark NS; Lyngbæk M; Oberholzer L; Elkjær I; Petersen-Bønding C; Kofoed K; Siebenmann C; Kellenberger K; van Hall G; Abildgaard J; Ellingsgaard H; Lauridsen C; Ried-Larsen M; Pedersen BK; Hansen KB; Karstoft K
Diabetologia; 2021 Feb; 64(2):397-409. PubMed ID: 32979074
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of an enhanced diabetes prevention program with psychosocial support for urban American Indians and Alaska natives: A randomized controlled trial.
Rosas LG; Vasquez JJ; Naderi R; Jeffery N; Hedlin H; Qin F; LaFromboise T; Megginson N; Pasqua C; Flores O; McClinton-Brown R; Evans J; Stafford RS
Contemp Clin Trials; 2016 Sep; 50():28-36. PubMed ID: 27381232
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of type 2 diabetes prevention through diet modification in people with impaired glucose regulation: A population-based study.
Khalangot MD; Kovtun VA; Gurianov VG; Pysarenko YM; Kravchenko VI
Prim Care Diabetes; 2019 Dec; 13(6):535-541. PubMed ID: 31023525
[TBL] [Abstract][Full Text] [Related]
37. (5) Prevention or delay of type 2 diabetes.
American Diabetes Association
Diabetes Care; 2015 Jan; 38 Suppl():S31-2. PubMed ID: 25537704
[No Abstract] [Full Text] [Related]
38. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
[TBL] [Abstract][Full Text] [Related]
39. Baseline level of 30-min plasma glucose is an independent predictor of incident diabetes among Asian Indians: analysis of two diabetes prevention programmes.
Chamukuttan S; Ram J; Nanditha A; Shetty AS; Sevick MA; Bergman M; Johnston DG; Ramachandran A
Diabetes Metab Res Rev; 2016 Oct; 32(7):762-767. PubMed ID: 26991329
[TBL] [Abstract][Full Text] [Related]
40. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
